PMC:7102591 / 10237-13583
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 333 | 833-835 | Gene | denotes | CS | Gene:1431 |
| 334 | 1208-1210 | Gene | denotes | CS | Gene:1431 |
| 335 | 974-976 | Gene | denotes | CS | Gene:1431 |
| 336 | 652-654 | Gene | denotes | CS | Gene:1431 |
| 337 | 323-325 | Gene | denotes | CS | Gene:1431 |
| 338 | 89-91 | Gene | denotes | CS | Gene:1431 |
| 339 | 697-705 | Species | denotes | patients | Tax:9606 |
| 340 | 811-819 | Species | denotes | patients | Tax:9606 |
| 341 | 955-963 | Species | denotes | patients | Tax:9606 |
| 342 | 1191-1198 | Species | denotes | patient | Tax:9606 |
| 343 | 109-111 | Disease | denotes | RA | MESH:D001172 |
| 344 | 292-294 | Disease | denotes | RA | MESH:D001172 |
| 345 | 358-370 | Disease | denotes | inflammation | MESH:D007249 |
| 346 | 378-380 | Disease | denotes | RA | MESH:D001172 |
| 347 | 504-514 | Disease | denotes | infections | MESH:D007239 |
| 348 | 592-601 | Disease | denotes | infection | MESH:D007239 |
| 349 | 680-690 | Disease | denotes | infections | MESH:D007239 |
| 350 | 694-696 | Disease | denotes | RA | MESH:D001172 |
| 351 | 794-804 | Disease | denotes | infections | MESH:D007239 |
| 352 | 808-810 | Disease | denotes | RA | MESH:D001172 |
| 353 | 952-954 | Disease | denotes | RA | MESH:D001172 |
| 354 | 1019-1035 | Disease | denotes | viral infections | MESH:D001102 |
| 355 | 1127-1144 | Disease | denotes | Zoster infections | MESH:D006562 |
| 371 | 1866-1868 | Gene | denotes | CS | Gene:1431 |
| 372 | 1242-1244 | Gene | denotes | CS | Gene:1431 |
| 373 | 1591-1593 | Gene | denotes | CS | Gene:1431 |
| 374 | 1650-1659 | Species | denotes | MERS)-CoV | Tax:1335626 |
| 375 | 1669-1677 | Species | denotes | SARS-CoV | Tax:694009 |
| 376 | 1445-1456 | Species | denotes | respiratory | Tax:12814 |
| 377 | 2017-2026 | Species | denotes | influenza | Tax:11309 |
| 378 | 1421-1437 | Disease | denotes | viral infections | MESH:D001102 |
| 379 | 1492-1503 | Disease | denotes | lung damage | MESH:D008171 |
| 380 | 1522-1526 | Disease | denotes | ARDS | MESH:D012128 |
| 381 | 1616-1648 | Disease | denotes | Middle East respiratory syndrome | MESH:D018352 |
| 382 | 1731-1748 | Disease | denotes | lung inflammation | MESH:D011014 |
| 383 | 1761-1776 | Disease | denotes | alveolar damage | MESH:D055370 |
| 384 | 1903-1912 | Disease | denotes | infection | MESH:D007239 |
| 385 | 2046-2055 | Disease | denotes | mortality | MESH:D003643 |
| 399 | 2598-2600 | Gene | denotes | CS | Gene:1431 |
| 400 | 2313-2315 | Gene | denotes | CS | Gene:1431 |
| 401 | 2784-2786 | Gene | denotes | CS | Gene:1431 |
| 402 | 2481-2483 | Gene | denotes | CS | Gene:1431 |
| 403 | 2294-2302 | Species | denotes | patients | Tax:9606 |
| 404 | 2414-2422 | Species | denotes | patients | Tax:9606 |
| 405 | 2547-2555 | Species | denotes | patients | Tax:9606 |
| 406 | 2135-2164 | Disease | denotes | bacterial or fungal infection | MESH:D001424 |
| 407 | 2366-2370 | Disease | denotes | ARDS | MESH:D012128 |
| 408 | 2561-2569 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 409 | 2570-2579 | Disease | denotes | infection | MESH:D007239 |
| 410 | 2738-2746 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 411 | 2747-2756 | Disease | denotes | infection | MESH:D007239 |
| 424 | 2969-2973 | Gene | denotes | ACE2 | Gene:302668 |
| 425 | 2996-3000 | Species | denotes | rats | Tax:10116 |
| 426 | 3134-3142 | Species | denotes | patients | Tax:9606 |
| 427 | 2906-2915 | Chemical | denotes | Ibuprofen | MESH:D007052 |
| 428 | 3189-3202 | Chemical | denotes | acetaminophen | MESH:D000082 |
| 429 | 2865-2881 | Disease | denotes | viral infections | MESH:D001102 |
| 430 | 2987-2995 | Disease | denotes | diabetic | MESH:D003920 |
| 431 | 3104-3112 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 432 | 3113-3122 | Disease | denotes | infection | MESH:D007239 |
| 433 | 3245-3255 | Disease | denotes | fever rise | MESH:D005334 |
| 434 | 3263-3271 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 435 | 3336-3345 | Disease | denotes | infection | MESH:D007239 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T49 | 89-91 | Body_part | denotes | CS | http://purl.org/sig/ont/fma/fma284995 |
| T50 | 323-325 | Body_part | denotes | CS | http://purl.org/sig/ont/fma/fma284995 |
| T51 | 652-654 | Body_part | denotes | CS | http://purl.org/sig/ont/fma/fma284995 |
| T52 | 833-835 | Body_part | denotes | CS | http://purl.org/sig/ont/fma/fma284995 |
| T53 | 974-976 | Body_part | denotes | CS | http://purl.org/sig/ont/fma/fma284995 |
| T54 | 1208-1210 | Body_part | denotes | CS | http://purl.org/sig/ont/fma/fma284995 |
| T55 | 1242-1244 | Body_part | denotes | CS | http://purl.org/sig/ont/fma/fma284995 |
| T56 | 1256-1260 | Body_part | denotes | hand | http://purl.org/sig/ont/fma/fma9712 |
| T57 | 1349-1353 | Body_part | denotes | hand | http://purl.org/sig/ont/fma/fma9712 |
| T58 | 1445-1462 | Body_part | denotes | respiratory tract | http://purl.org/sig/ont/fma/fma265130 |
| T59 | 1492-1496 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
| T60 | 1591-1593 | Body_part | denotes | CS | http://purl.org/sig/ont/fma/fma284995 |
| T61 | 1731-1735 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
| T62 | 1761-1769 | Body_part | denotes | alveolar | http://purl.org/sig/ont/fma/fma264783 |
| T63 | 1866-1868 | Body_part | denotes | CS | http://purl.org/sig/ont/fma/fma284995 |
| T64 | 2313-2315 | Body_part | denotes | CS | http://purl.org/sig/ont/fma/fma284995 |
| T65 | 2481-2483 | Body_part | denotes | CS | http://purl.org/sig/ont/fma/fma284995 |
| T66 | 2598-2600 | Body_part | denotes | CS | http://purl.org/sig/ont/fma/fma284995 |
| T67 | 2784-2786 | Body_part | denotes | CS | http://purl.org/sig/ont/fma/fma284995 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T16 | 1256-1260 | Body_part | denotes | hand | http://purl.obolibrary.org/obo/UBERON_0002398 |
| T17 | 1349-1353 | Body_part | denotes | hand | http://purl.obolibrary.org/obo/UBERON_0002398 |
| T18 | 1445-1462 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
| T19 | 1492-1496 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
| T20 | 1731-1735 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid_AGAC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| p51590s23 | 3042-3050 | PosReg | denotes | increase |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T139 | 109-111 | Disease | denotes | RA | http://purl.obolibrary.org/obo/MONDO_0005272|http://purl.obolibrary.org/obo/MONDO_0008383 |
| T141 | 292-294 | Disease | denotes | RA | http://purl.obolibrary.org/obo/MONDO_0005272|http://purl.obolibrary.org/obo/MONDO_0008383 |
| T143 | 358-370 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
| T144 | 378-380 | Disease | denotes | RA | http://purl.obolibrary.org/obo/MONDO_0005272|http://purl.obolibrary.org/obo/MONDO_0008383 |
| T146 | 504-514 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T147 | 592-601 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T148 | 680-693 | Disease | denotes | infections in | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T149 | 694-696 | Disease | denotes | RA | http://purl.obolibrary.org/obo/MONDO_0005272|http://purl.obolibrary.org/obo/MONDO_0008383 |
| T151 | 794-807 | Disease | denotes | infections in | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T152 | 808-810 | Disease | denotes | RA | http://purl.obolibrary.org/obo/MONDO_0005272|http://purl.obolibrary.org/obo/MONDO_0008383 |
| T154 | 903-913 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T155 | 952-954 | Disease | denotes | RA | http://purl.obolibrary.org/obo/MONDO_0005272|http://purl.obolibrary.org/obo/MONDO_0008383 |
| T157 | 1019-1035 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
| T158 | 1127-1133 | Disease | denotes | Zoster | http://purl.obolibrary.org/obo/MONDO_0005609 |
| T159 | 1134-1144 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T160 | 1421-1437 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
| T161 | 1522-1526 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
| T162 | 1669-1677 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T163 | 1736-1748 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
| T164 | 1903-1912 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T165 | 2017-2026 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
| T166 | 2148-2164 | Disease | denotes | fungal infection | http://purl.obolibrary.org/obo/MONDO_0002041 |
| T167 | 2155-2164 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T168 | 2366-2370 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
| T169 | 2561-2569 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T170 | 2570-2579 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T171 | 2738-2746 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T172 | 2747-2756 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T173 | 2865-2881 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
| T174 | 3104-3112 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T175 | 3113-3122 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T176 | 3263-3271 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T177 | 3336-3345 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T81 | 35-38 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T82 | 216-219 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T83 | 306-308 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
| T84 | 720-722 | http://purl.obolibrary.org/obo/CLO_0053794 | denotes | 41 |
| T85 | 850-851 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T86 | 985-986 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T87 | 1052-1053 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T88 | 1492-1496 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
| T89 | 1492-1496 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
| T90 | 1679-1681 | http://purl.obolibrary.org/obo/CLO_0053799 | denotes | 45 |
| T91 | 1731-1735 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
| T92 | 1731-1735 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
| T93 | 1831-1832 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T94 | 1914-1915 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T95 | 1967-1970 | http://purl.obolibrary.org/obo/CLO_0050884 | denotes | ten |
| T96 | 2178-2182 | http://purl.obolibrary.org/obo/CLO_0037048 | denotes | CI 1 |
| T97 | 2332-2333 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T98 | 2399-2400 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T99 | 2495-2497 | http://purl.obolibrary.org/obo/CLO_0001382 | denotes | 48 |
| T100 | 2916-2919 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T101 | 3228-3229 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T102 | 3286-3287 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T69 | 25-31 | Chemical | denotes | NSAIDs | http://purl.obolibrary.org/obo/CHEBI_35475 |
| T70 | 72-87 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
| T71 | 89-91 | Chemical | denotes | CS | http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858 |
| T73 | 109-111 | Chemical | denotes | RA | http://purl.obolibrary.org/obo/CHEBI_73810 |
| T74 | 292-294 | Chemical | denotes | RA | http://purl.obolibrary.org/obo/CHEBI_73810 |
| T75 | 323-325 | Chemical | denotes | CS | http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858 |
| T77 | 378-380 | Chemical | denotes | RA | http://purl.obolibrary.org/obo/CHEBI_73810 |
| T78 | 652-654 | Chemical | denotes | CS | http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858 |
| T80 | 694-696 | Chemical | denotes | RA | http://purl.obolibrary.org/obo/CHEBI_73810 |
| T81 | 808-810 | Chemical | denotes | RA | http://purl.obolibrary.org/obo/CHEBI_73810 |
| T82 | 833-835 | Chemical | denotes | CS | http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858 |
| T84 | 952-954 | Chemical | denotes | RA | http://purl.obolibrary.org/obo/CHEBI_73810 |
| T85 | 974-976 | Chemical | denotes | CS | http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858 |
| T87 | 1208-1210 | Chemical | denotes | CS | http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858 |
| T89 | 1242-1244 | Chemical | denotes | CS | http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858 |
| T91 | 1591-1593 | Chemical | denotes | CS | http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858 |
| T93 | 1866-1868 | Chemical | denotes | CS | http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858 |
| T95 | 2069-2071 | Chemical | denotes | RR | http://purl.obolibrary.org/obo/CHEBI_73811 |
| T96 | 2166-2168 | Chemical | denotes | RR | http://purl.obolibrary.org/obo/CHEBI_73811 |
| T97 | 2313-2315 | Chemical | denotes | CS | http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858 |
| T99 | 2481-2483 | Chemical | denotes | CS | http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858 |
| T101 | 2598-2600 | Chemical | denotes | CS | http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858 |
| T103 | 2784-2786 | Chemical | denotes | CS | http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858 |
| T105 | 2841-2847 | Chemical | denotes | NSAIDs | http://purl.obolibrary.org/obo/CHEBI_35475 |
| T106 | 2906-2915 | Chemical | denotes | Ibuprofen | http://purl.obolibrary.org/obo/CHEBI_5855 |
| T107 | 3178-3184 | Chemical | denotes | NSAIDs | http://purl.obolibrary.org/obo/CHEBI_35475 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T15 | 358-370 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
| T16 | 1019-1035 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infections |
| T17 | 1261-1288 | http://purl.obolibrary.org/obo/GO_0050777 | denotes | inhibit the immune response |
| T18 | 1273-1288 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
| T19 | 1377-1398 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammatory response |
| T20 | 1421-1437 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infections |
| T21 | 1736-1748 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
| T22 | 2865-2881 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infections |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T54 | 0-31 | Sentence | denotes | 4.1 Corticosteroids and NSAIDs |
| T55 | 32-310 | Sentence | denotes | It has now been more than 70 years that corticosteroids (CS) are pivotal for RA management and their role as remission inducer and bridging therapy for the management of disease flare has recently been renewed by the latest update of EULAR recommendations for RA treatment [36]. |
| T56 | 311-610 | Sentence | denotes | Even though CS efficacy in rapidly suppressing inflammation during RA initial course or flares is well recognized [37], their downside is the broad spectrum of adverse events, including severe infections and the high risk of developing comorbidities further increasing the risk of infection [27,38]. |
| T57 | 611-880 | Sentence | denotes | Although RCTs conducted in the past with CS showed no higher risk of infections in RA patients [[39], [40], [41]], cohort and case-control studies reported increased rates of overall infections in RA patients treated with CS, according to a dose-dependent fashion [42]. |
| T58 | 881-1036 | Sentence | denotes | The majority of these infectious events are of bacterial etiology, but RA patients receiving CS exhibit a greater risk of developing even viral infections. |
| T59 | 1037-1235 | Sentence | denotes | As an example, a 2012 retrospective cohort-study demonstrated an increased risk of Herpes Zoster infections with an incidence rate of 8.54 cases per 1000 patient-years in CS treated population [29]. |
| T60 | 1236-1532 | Sentence | denotes | Thus, CS on the one hand inhibit the immune response and delay the clearance of the pathogen, while on the other hand they suppress the host inflammatory response, which in the case of viral infections of the respiratory tract is the major responsible for lung damage and occurrence of ARDS [43]. |
| T61 | 1533-1782 | Sentence | denotes | The latter represented the rational for the widely use of CS for the management of Middle East respiratory syndrome (MERS)-CoV [44] and SARS-CoV [45] outbreaks, both histologically characterized by lung inflammation and diffuse alveolar damage [46]. |
| T62 | 1783-1913 | Sentence | denotes | However, evidence from the literature points to a predominantly negative effect of CS in the management of this type of infection. |
| T63 | 1914-2106 | Sentence | denotes | A 2019 systematic review and meta-analysis including ten observational studies (n = 6548) conducted in influenza reported increased mortality (risk ratio [RR] 1.75, 95% CI 1.3–2.4; p = .0002), |
| T64 | 2107-2321 | Sentence | denotes | increased rate of secondary bacterial or fungal infection (RR 2·0, 95% CI 1·0–3·8; p = .04), and longer stay in an intensive care unit (mean difference 2.1, 95% CI 1.2–3.1; p < .0001) in patients receiving CS [47]. |
| T65 | 2322-2499 | Sentence | denotes | Moreover, a review exploring treatments for ARDS, including six studies with a total of 574 patients, concluded that insufficient evidence exists to recommend CS treatment [48]. |
| T66 | 2500-2668 | Sentence | denotes | Overall, no clear reason exists to expect that patients with COVID-19 infection will benefit from CS, and they might be more likely to be harmed with such therapy [49]. |
| T67 | 2669-2828 | Sentence | denotes | In fact, current interim guidance from WHO on clinical management of COVID-19 infection advises against the use of CS unless indicated for another reason [10]. |
| T68 | 2829-2905 | Sentence | denotes | The role of NSAIDs in the course of viral infections is still controversial. |
| T69 | 2906-3148 | Sentence | denotes | Ibuprofen has been demonstrated to induce an overexpression of ACE2 when used in diabetic rats [50] and this effect might theoretically increase the susceptibility and worsen the clinical course of COVID-19 infection in treated patients [15]. |
| T70 | 3149-3346 | Sentence | denotes | In addition, the use of both NSAIDs and acetaminophen could be associated with a masking of the fever rise during COVID-19, resulting in a delay in diagnosis and proper management of the infection. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T50 | 109-111 | Phenotype | denotes | RA | http://purl.obolibrary.org/obo/HP_0001370 |
| T51 | 292-294 | Phenotype | denotes | RA | http://purl.obolibrary.org/obo/HP_0001370 |
| T52 | 378-380 | Phenotype | denotes | RA | http://purl.obolibrary.org/obo/HP_0001370 |
| T53 | 497-514 | Phenotype | denotes | severe infections | http://purl.obolibrary.org/obo/HP_0032169 |
| T54 | 694-696 | Phenotype | denotes | RA | http://purl.obolibrary.org/obo/HP_0001370 |
| T55 | 808-810 | Phenotype | denotes | RA | http://purl.obolibrary.org/obo/HP_0001370 |
| T56 | 952-954 | Phenotype | denotes | RA | http://purl.obolibrary.org/obo/HP_0001370 |
| T57 | 1753-1776 | Phenotype | denotes | diffuse alveolar damage | http://purl.obolibrary.org/obo/HP_0033006 |
| T58 | 3245-3250 | Phenotype | denotes | fever | http://purl.obolibrary.org/obo/HP_0001945 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32205186-31396235-4826883 | 426-428 | 31396235 | denotes | 37 |
| 32205186-23192911-4826884 | 603-605 | 23192911 | denotes | 27 |
| 32205186-17870034-4826885 | 606-608 | 17870034 | denotes | 38 |
| 32205186-9251634-4826886 | 708-710 | 9251634 | denotes | 39 |
| 32205186-22393128-4826887 | 720-722 | 22393128 | denotes | 41 |
| 32205186-21884589-4826888 | 876-878 | 21884589 | denotes | 42 |
| 32205186-16195357-4826889 | 1528-1530 | 16195357 | denotes | 43 |
| 32205186-30917856-4826890 | 2317-2319 | 30917856 | denotes | 47 |
| 32205186-25896805-4826891 | 3002-3004 | 25896805 | denotes | 50 |